Sabra Health Care Reit, Inc. · NASDAQ:SBRA

Sabra Health Care Reit — REITWeek 2013

25 slides from Sabra Health Care Reit's conference presentation, Jun 5, 2013

  1. Slide 1: REITWeek 2013

    HEALTH CARE REIT, ING. REITWeek 2013 June 5-7, 2013 ——

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS 2 This presentation contains “forward-looking” statements that may be identified, without limitation, by the use of “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. Forward-looking statements in this presentation also include all stat

  3. Slide 3: Non-GAAP Financial Measures

    NON-GAAP FINANCIAL MEASURES 3 This presentation includes the following financial measures defined as non-GAAP financial measures by the SEC: EBITDAR, EBITDARM, funds from operations (“FFO”), Normalized FFO, adjusted FFO (“AFFO”), and Normalized AFFO. These measures may be different than non-GAAP fin

  4. Slide 4: Strategic Overview

    Strategic Overview ASABRA

  5. Slide 5: Market Thesis

    5 MARKET THESIS • “Big Three” Health Care REITS: Elephant hunters • Smaller operators lack capital Market Conditions Opportunity Health care industry is extremely fragmented Limited capital flowing to local & regional operators Arbitrage between public and private markets Strategy Partner to smaller

  6. Slide 6: Investment Thesis: Focus on needs-driven facilities

    INVESTMENT THESIS 6 Focus on needs-driven facilities Observations • Quality of operator critical • SNFs remain low-cost option for ◦ ◦ care • Not all operators are “mom & pop” • Building age less important Investment Characteristics • Quality of care • Market location • Relationship with referral so

  7. Slide 7: Opportunistic Investing

    OPPORTUNISTIC INVESTING 7 SNF AL / MC IL Acute Care Hospital Equity   Mezzanine Debt  Mortgage Debt   RIDEA   Development    Creative approaches to meet operators’ needs         

  8. Slide 8: Impact of Acquisitions: Annualized Revenue by Tenant

    8 As of December 31, 2010 As of March 31, 2013, 36.8% of total annualized revenue derived from acquisitions Sabra’s Annualized Revenue: By Tenant IMPACT OF ACQUISITIONS $70.2 million $94.6 million As of December 31, 2011 As of March 31, 2013 $128.9 million

  9. Slide 9: Diversifying portfolio across spectrum of health care

    9 Diversifying portfolio across spectrum of health care Sabra’s Annualized Revenue: By Asset Class IMPACT OF ACQUISITIONS As of December 31, 2011 As of March 31, 2013 As of December 31, 2010

  10. Slide 10: Acquisition Case Study: Meridian

    10 Crafting solutions: Building relationships * * * * * ACQUISITION CASE STUDY: MERIDIAN * * * * * Experienced SNF developers transforming from merchant builder to sustainable business model Dec. 2010: Introduced to Meridian as potential JV partner in SNF development program Mar. 2012: Sabra closes

  11. Slide 11: Acquisition Case Study: Stoney River

    11 * Sabra grows as partnerships flourish * * * * ACQUISITION CASE STUDY: STONEY RIVER * * * * * * Sep. 2011: Introduced to Stoney River principals through an equity partner Dec. 2011: Sabra tours Stoney River – Marshfield in Central Wisconsin Aug. 2012: Signed agreement to proceed with development

  12. Slide 12: Acquisition Case Study: New Dawn

    12 * Partnering to create next generation of memory care facilities * * * * ACQUISITION CASE STUDY: NEW DAWN * * * * * * Jul. 2012: Sabra introduced to New Dawn through its financial advisor Sep. 2012: Closed sale/leaseback on Aurora, Colorado facility Oct. 2012: Explored partial recapitalization of

  13. Slide 13: Financial Overview

    Financial Overview ASABRA

  14. Slide 14: Financial Strength

    14 FINANCIAL STRENGTH (dollars in millions) $461 $225 $161 As of December 31, 2010 $1,083 $415 $144 $144 Pro forma as of March 31, 2013 Common Equity Market Value Senior Notes Mortgage Debt Preferred Equity Capitalization $847 million $1.79 billion Track record of access to capital markets (1) Assum

  15. Slide 15: Financial Results

    FINANCIAL RESULTS 15 Normalized AFFO/share & Normalized FFO/share Normalized AFFO/share & dividend/share $0.40 $0.38 $0.37 $0.38 $0.42 $0.39 $0.41 $0.43 $0.39 $0.32 $0.32 $0.32 $0.33 $0.33 $0.33 $0.33 $0.34 $0.34 $0.00 $0.10 $0.20 $0.30 $0.40 $0.50 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4

  16. Slide 16: Strong Portfolio Performance

    16 Historical overall occupancy(1) Historical SNF portfolio skilled mix(1) (2) STRONG PORTFOLIO PERFORMANCE (as of March 31, 2013) 41.3% 37.5% 38.6% 36.5% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 50.0% Trailing 12 Months, Q1 2012 Trailing 12 Months, Q1 2013 Q1 2012 Q1 2013 88.5% 88.3% 88.2% 87.9% 85.0% 8

  17. Slide 17: Tenant Coverage Analysis

    17 EBITDAR Coverage (1) EBITDARM Coverage (1) TENANT COVERAGE ANALYSIS (as of March 31, 2013) 1.31x 1.26x 1.50x 1.26x 1.00x 1.10x 1.20x 1.30x 1.40x 1.50x 1.60x Trailing 3 months, Q1 2012 Trailing 3 months, Q1 2013 Trailing 12 months, Q1 2012 Trailing 12 months, Q1 2013 (1) EBITDAR Coverage and EBITD

  18. Slide 18: Tenant Coverage Analysis

    18 EBITDAR Coverage (1) (2) EBITDARM Coverage (1) (2) TENANT COVERAGE ANALYSIS (as of March 31, 2013) 1.21x 1.13x 1.28x 1.11x 1.00x 1.10x 1.20x 1.30x 1.40x 1.50x Trailing 3 months, Q1 2012 Trailing 3 months, Q1 2013 Trailing 12 months, Q1 2012 Trailing 12 months, Q1 2013 (1) EBITDAR Coverage and EBI

  19. Slide 19: Financial Strength

    2.18x 1.85x 1.76x 1.67x 2.03x 1.53x 2.03x 1.24x 1.19x 3.07x 2.60x 2.50x 2.37x 2.26x 3.15x 2.69x 2.65x 3.36x 0.00x 1.00x 2.00x 3.00x 4.00x 5.00x 6.00x Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 PF Q1 2013 Secured Leverage Unsecured Leverage 4.04x 4.55x FINANCIAL STRENGTH 19 LTM C

  20. Slide 20: Financial Strength: Pro Forma Debt Maturities

    FINANCIAL STRENGTH 20 Pro Forma Debt Maturities (1) (dollars in millions) $3.0 $3.7 $86.0 $1.7 $1.7 $1.7 $1.8 $1.8 $1.9 $2.8 $3.5 $34.7 $194.0 $0 $50 $100 $150 $200 $250 $300 $350 Mortgage Notes Outstanding Revolver Unused Revolver Senior Notes $200.0 $211.3 $86.5 Pro forma liquidity of $319.6 milli

  21. Slide 21: Virtuous Cycle

    21 Make accretive investments Diversify from Genesis Diversify payor sources Lower risk Lower cost of capital and enhance competitive position Higher AFFO VIRTUOUS CYCLE

  22. Slide 22: Appendix

    Appendix ASABRA

  23. Slide 23: Debt Covenants

    DEBT COVENANTS (1) 23 (1) Based on defined terms in the 2018 senior notes indenture and the amended credit agreement. (2) Information assumes the origination of the Sun City West Mortgage Loan and Bee Cave Preferred Equity Investment, the repayment of the revolving credit facility, the repayment of

  24. Slide 24: Reconciliation of FFO, Normalized FFO, AFFO and Normalized AFFO

    24 Reconciliation of Funds from Operations (FFO), Normalized FFO, Adjusted Funds from Operations (AFFO) and Normalized AFFO (1) Information assumes the origination of the Sun City West Mortgage Loan and Bee Cave Preferred Equity Investment, the repayment of the revolving credit facility, the repayme

  25. Slide 25: Definitions

    DEFINITIONS 25 Acute Care Hospital. A facility designed to provide extended medical and rehabilitation care for patients who are clinically complex and have multiple acute or chronic conditions. EBITDAR Coverage. EBITDAR for the trailing 3 and 12 month periods prior to and including the period prese

Sabra Health Care REIT — REITWeek 2013 on 6ix